XML 58 R45.htm IDEA: XBRL DOCUMENT v3.25.1
Note 18 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Notes Tables  
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
   

Year ended December 31,

 
   

2024

   

2023

 

Domestic

  $ (4,286 )   $ (3,527 )

Foreign

    4,312       2,594  

Total

  $ 26     $ (933 )
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
   

Year ended December 31,

 
   

2024

   

2023

 

Current:

               

Federal

  $ 0     $ 0  

State

    9       10  

Foreign

    1,465       599  

Total current income tax expense

    1,474       609  
                 

Deferred:

               

Federal

    0       0  

State

    0       0  

Foreign

    232       54  

Total deferred income tax expense

    232       54  

Income tax expense, net

  $ 1,706     $ 663  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
   

Year ended December 31,

 
   

2024

   

2023

 

Federal tax expense at the statutory rate

  $ 5     $ (196 )

Current year permanent differences

    326       35  

State income taxes, net of federal tax impact

    (90 )     (72 )

Effect of tax rates of foreign subsidiary

    400       235  

Return to provision

    150       (35 )

Change in valuation allowance

    915       469  

Research & experimental tax credit expiration

    0       227  

Income tax expense (benefit), net

  $ 1,706     $ 663  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
   

Year ended December 31,

 
   

2024

   

2023

 

Deferred tax assets:

               

Compensation and benefit accruals

  $ 554     $ 525  

Inventory valuation

    945       848  

Federal and state net operating loss carryforwards

    36,463       34,980  

Deferred revenue

    23       848  

Interest limitation carryover

    873       586  

Defined benefit pension plan

    21       305  

Lease liabilities

    864       673  

Foreign deferred revenue and other provisions

    2,047       2,657  

Capitalized research and experimental costs

    201       201  

Other

    350       381  

Total

    42,341       42,004  

Domestic valuation allowance

    (38,748

)

    (38,222

)

Total deferred tax assets

    3,593       3,782  
                 

Deferred tax liabilities:

               

Prepaid and other assets

    (787

)

    (589

)

Right-of-use assets, net

    (759

)

    (536

)

Total deferred tax liabilities

    (1,546

)

    (1,125

)

Net deferred tax asset

  $ 2,047     $ 2,657